Water

Water

SCHEMBL29088767

COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(CP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC.O.O.O.O.O.O.[NaH].[NaH]

nearest known ligand 0.82

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Water. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK known ✓ P43405 13/20 0.82
▸ FLT3 known ✓ P36888 2/20 0.82
▸ KDR known ✓ P35968 2/20 0.79
▸ EGFR known ✓ P00533 3/20 0.62
▸ ADORA3 known ✓ P0DMS8 2/20 0.62
▸ BTK known ✓ Q06187 2/20 0.62
▸ PIK3CD known ✓ O00329 1/20 0.62
▸ JAK2 known ✓ O60674 1/20 0.62
▸ ROCK2 known ✓ O75116 1/20 0.62
▸ ABL1 known ✓ P00519 1/20 0.62
▸ ERBB2 known ✓ P04626 1/20 0.62
▸ MET known ✓ P08581 1/20 0.62
▸ PDGFRB known ✓ P09619 1/20 0.62
▸ KIT known ✓ P10721 1/20 0.62
▸ FLT1 known ✓ P17948 1/20 0.62
▸ JAK1 known ✓ P23458 1/20 0.62
▸ TYK2 known ✓ P29597 1/20 0.62
▸ FLT4 known ✓ P35916 1/20 0.62
▸ GSK3A known ✓ P49840 1/20 0.62
▸ GSK3B known ✓ P49841 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28489482 0.99 SYK (0.84) SYKPTK2PLK4AURKASTK16
Fostamatinib SCHEMBL28519986 0.92 SYK (0.97) SYKPTK2PLK4AURKASTK16
Water SCHEMBL28356634 0.91 SYK (0.85) SYKPTK2PLK4AURKASTK16
SCHEMBL16858283 0.91 SYK (0.82) SYKPTK2PLK4AURKASTK16
Fostamatinib SCHEMBL22164570 0.91 SYK (0.99) SYKPTK2PLK4AURKASTK16
Fostamatinib SCHEMBL16820327 0.91 SYK (0.99) SYKPTK2PLK4AURKASTK16
Fostamatinib SCHEMBL1201371 0.90 SYK (1.00) SYKPTK2PLK4AURKASTK16
Fostamatinib SCHEMBL29351337 0.90 SYK (1.00) SYKPTK2PLK4AURKASTK16
SCHEMBL4108129 0.90 SYK (0.81) SYKPTK2PLK4AURKASTK16
SCHEMBL13451994 0.89 SYK (0.91) SYKPTK2PLK4AURKASTK16

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116897150-A Novel bifunctional molecules for protein-targeted degradation 安菲斯塔治疗有限公司 2023-10-17 — — CN disclosed
Send feedback